These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2201691)

  • 1. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
    J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; FitzGerald DJ; Chaudhary VK; Pastan I; Heinrikson RL
    J Biol Chem; 1990 Jan; 265(1):408-13. PubMed ID: 2104621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow CA; Reardon IM; Chaudhary VK; Fryling CM; Pastan I; Fitzgerald DJ
    J Virol; 1990 Jul; 64(7):3157-61. PubMed ID: 2161935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
    Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
    Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.
    Beck ZQ; Lin YC; Elder JH
    J Virol; 2001 Oct; 75(19):9458-69. PubMed ID: 11533208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
    Margolin N; Heath W; Osborne E; Lai M; Vlahos C
    Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
    Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
    J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.
    Konvalinka J; Strop P; Velek J; Cerna V; Kostka V; Phylip LH; Richards AD; Dunn BM; Kay J
    FEBS Lett; 1990 Jul; 268(1):35-8. PubMed ID: 2200711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
    Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
    Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
    Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
    J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
    Matayoshi ED; Wang GT; Krafft GA; Erickson J
    Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
    Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
    Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites.
    Griffiths JT; Phylip LH; Konvalinka J; Strop P; Gustchina A; Wlodawer A; Davenport RJ; Briggs R; Dunn BM; Kay J
    Biochemistry; 1992 Jun; 31(22):5193-200. PubMed ID: 1606143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
    Partin K; Kräusslich HG; Ehrlich L; Wimmer E; Carter C
    J Virol; 1990 Aug; 64(8):3938-47. PubMed ID: 2196384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.
    Phylip LH; Richards AD; Kay J; Kovalinka J; Strop P; Blaha I; Velek J; Kostka V; Ritchie AJ; Broadhurst AV
    Biochem Biophys Res Commun; 1990 Aug; 171(1):439-44. PubMed ID: 2203349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the role of the S4 substrate binding site of HIV proteinases.
    Tözsér J; Gustchina A; Weber IT; Blaha I; Wondrak EM; Oroszlan S
    FEBS Lett; 1991 Feb; 279(2):356-60. PubMed ID: 2001747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.
    Mulichak AM; Hui JO; Tomasselli AG; Heinrikson RL; Curry KA; Tomich CS; Thaisrivongs S; Sawyer TK; Watenpaugh KD
    J Biol Chem; 1993 Jun; 268(18):13103-9. PubMed ID: 8514751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of cucumisin on synthetic peptides.
    Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.